Company Number: 13126864

Analysis Date: 2025-07-20 13:09 UTC

Financial Health Assessment Report for AGILEFINANCEUK LTD

---

1. Financial Health Score: B

Explanation:
AGILEFINANCEUK LTD shows strong growth, profitability, and a solid net asset position for a micro-entity. The company demonstrates healthy cash flow and working capital management, with profitability increasing significantly year-on-year. However, as a micro entity with a single employee and modest scale, there is limited diversification and scale-related risk. The score reflects good financial wellness with room for improvement in operational scale and risk management.

---

2. Key Vital Signs

Metric	2025 (£)	Interpretation
Turnover	161,552	Strong revenue growth from £83,850 (2024) and £8,385 (2023), indicating expanding business demand.
Profit for the Period	112,172	High profit margin (~70%), indicating efficient cost control and robust profitability.
Staff Costs	26,851	Low staff costs consistent with a single-employee micro company, showing lean operation.
Current Assets	79,667	Healthy liquidity; significant increase from prior years, indicating strong cash or receivables.
Current Liabilities	28,447	Manageable short-term obligations; current assets comfortably cover liabilities.
Net Current Assets (Working Capital)	51,220	Positive working capital signals good short-term financial health and ability to meet obligations.
Net Assets (Equity)	51,221	Increasing equity base shows retained earnings accumulation and growing shareholder value.
Average Number of Employees	1	Micro-scale operation; dependency on limited human resources is a potential risk.

---

3. Diagnosis: What the Financial Data Reveals

AGILEFINANCEUK LTD exhibits the "vital signs" of a financially healthy micro-business. The company has demonstrated rapid growth in turnover, more than doubling in the latest financial year, which is a positive symptom indicating increasing market traction and demand for its management consultancy services.

The profitability is notably high relative to turnover, reflecting efficient cost management and possibly the benefit of a lean, one-person operation. The healthy net current assets show that the company maintains a comfortable liquidity buffer, which is akin to a patient having a strong pulse and good oxygen saturation — key indicators of financial robustness.

The build-up in net assets and shareholder funds from £2,237 in 2024 to £51,221 in 2025 is particularly encouraging, suggesting the business is accumulating reserves and strengthening its balance sheet rather than relying on external borrowing or incurring losses.

However, the micro-entity status and sole employee mean there is limited operational redundancy or diversification. This presents a potential "symptom of vulnerability" as the business may be susceptible to risks such as reliance on a single director/operator or client concentration. Growth has been impressive but sustaining this trajectory will require strategic planning and possibly scaling human resources to avoid overexertion and operational bottlenecks.

---

4. Recommendations

a) Strengthen Operational Capacity:

• Consider hiring additional staff or subcontractors to diversify skills and reduce dependency on a single individual. This will enhance resilience and support sustained growth.

b) Maintain Healthy Cash Flow:

• Continue monitoring working capital closely to ensure liquidity remains robust, especially if scaling up operations or investing in marketing to capture more clients.

c) Diversify Client Base:

• To avoid concentration risk, aim to expand the client portfolio to reduce dependency on a small number of customers, improving revenue stability.

d) Formal Financial Planning & Budgeting:

• Implement regular financial forecasting and budgeting tools to anticipate cash flow needs, manage costs, and plan for tax obligations.

e) Consider Gradual Scale-Up:

• Explore strategies to increase turnover beyond the current micro thresholds to benefit from economies of scale, but balance this with cost control to preserve profitability.

f) Risk Management & Compliance:

• Ensure compliance with all filing deadlines and regulatory requirements remains timely to avoid penalties, as currently observed.

---